A detailed history of Staley Capital Advisers Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Staley Capital Advisers Inc holds 8,045 shares of MRK stock, worth $817,693. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,045
Previous 8,045 -0.0%
Holding current value
$817,693
Previous $995,000 8.24%
% of portfolio
0.04%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $15,103 - $16,221
-122 Reduced 1.49%
8,045 $995,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $41,077 - $45,617
-399 Reduced 4.66%
8,167 $840,000
Q2 2023

Aug 15, 2023

BUY
$108.61 - $118.38 $1,629 - $1,775
15 Added 0.18%
8,566 $988,000
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $96,533 - $108,444
1,142 Added 15.41%
8,551 $736,000
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $7,351 - $8,240
-100 Reduced 1.33%
7,409 $608,000
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $7,228 - $9,054
100 Added 1.35%
7,509 $575,000
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $37,264 - $41,218
-530 Reduced 6.68%
7,409 $576,000
Q1 2021

May 06, 2021

SELL
$68.86 - $81.11 $50,818 - $59,859
-738 Reduced 8.51%
7,939 $612,000
Q2 2020

Aug 07, 2020

BUY
$70.42 - $80.13 $68,096 - $77,485
967 Added 12.54%
8,677 $671,000
Q3 2019

Nov 08, 2019

BUY
$76.08 - $82.93 $356,434 - $388,527
4,685 Added 154.88%
7,710 $649,000
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $81,130 - $92,533
-1,166 Reduced 27.82%
3,025 $252,000
Q2 2018

Aug 08, 2018

SELL
$50.83 - $59.72 $82,039 - $96,388
-1,614 Reduced 27.8%
4,191 $254,000
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $86,071 - $100,039
-1,689 Reduced 22.54%
5,805 $316,000
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $109,124 - $130,306
2,114 Added 39.29%
7,494 $422,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,380
5,380 $345,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Staley Capital Advisers Inc Portfolio

Follow Staley Capital Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Staley Capital Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Staley Capital Advisers Inc with notifications on news.